Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implant contraception.

K R Meckstroth1, P D Darney

  • 1Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco General Hospital, University of California, San Francisco, California 94110, USA.

Seminars in Reproductive Medicine
|December 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2007
Same author

Contraception-associated menstrual problems: etiology and management.

Dialogues in contraception·2002
Same author

Practice guidelines for OC selection: update.

Dialogues in contraception·2002
Same author

Misoprostol: a boon to safe motherhood...or not?

Lancet (London, England)·2001
Same author

Time to pardon the IUD?

The New England journal of medicine·2001
Same author

Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion.

Contraception·2001
Same journal

Understanding PGT-M: A Guide for Clinicians.

Seminars in reproductive medicine·2026
Same journal

Genetics in Reproduction.

Seminars in reproductive medicine·2026
Same journal

Genetics in Reproduction.

Seminars in reproductive medicine·2026
Same journal

Clinical Genetics in Reproductive Medicine: Variant Classification, Medically Actionable Genes, and Carrier Screening.

Seminars in reproductive medicine·2026
Same journal

Clinical Testing for Genetic Conditions.

Seminars in reproductive medicine·2026
Same journal

Genetics of Primary Ovarian Insufficiency.

Seminars in reproductive medicine·2026
See all related articles

Implanon is a new single-rod contraceptive implant offering high efficacy and a rapid return to fertility. This advanced implant prevents pregnancy by inhibiting ovulation and is suitable for various women, including those with medical conditions.

Area of Science:

  • Contraceptive Technology
  • Reproductive Health
  • Pharmacology

Background:

  • Norplant, a previous contraceptive implant, has been used by millions.
  • Advancements in implant technology have led to newer systems like Implanon.
  • Implanon represents a next-generation contraceptive implant.

Purpose of the Study:

  • To introduce Implanon, a novel single-rod contraceptive implant.
  • To describe Implanon's mechanism of action and advantages over previous systems.
  • To discuss the suitability and potential benefits of Implanon for diverse patient populations.

Main Methods:

  • Implanon utilizes a single-rod system containing a low androgenic progestin.
  • Insertion and removal procedures for Implanon are brief, taking 1-2 minutes.

Related Experiment Videos

  • The implant functions by altering cervical mucus and inhibiting ovulation.
  • Main Results:

    • Implanon offers high contraceptive efficacy.
    • Advantages include minimal maintenance, estrogen absence, and quick fertility return.
    • Irregular bleeding is the most common side effect, manageable with treatment.

    Conclusions:

    • Implant contraception, including Implanon, provides significant benefits.
    • It is a viable option for adolescents and women with specific medical conditions.
    • Effective counseling is crucial for user satisfaction with contraceptive implants.